Atypical antipsychotic

Geodon (ziprasidone) Withdrawal

Geodon (ziprasidone) has a moderate discontinuation profile. The shorter half-life means rebound effects can emerge quickly. Less commonly prescribed than other atypicals but used for both schizophrenia and bipolar disorder.

By Dr. Ben Soffer, DO — board-certified physician, at-home ketamine therapy in Florida and New Jersey.

Half-life

~7 hours.

Withdrawal timeline

Onset— 1-3 days after stopping

Symptoms emerge within days given the short half-life.

Peak— Week 1

Rebound effects peak in the first week.

Resolution— 2-3 weeks acute; relapse risk extends longer

Acute symptoms resolve over weeks; relapse is separate.

Common symptoms

  • Rebound insomnia
  • Anxiety
  • Restlessness
  • Return of underlying condition

Less common

  • Headache
  • Withdrawal dyskinesia (rare)

Tapering guidance

  • A typical taper reduces by 20-40 mg every 1-2 weeks.
  • Coordinate the taper with the prescribing psychiatrist.

Where ketamine therapy fits

Geodon is compatible with at-home ketamine therapy. Continue Geodon as prescribed during ketamine treatment unless the prescribing psychiatrist advises otherwise.

Check ketamine therapy eligibilityMedication safety with ketamine

Frequently asked questions

How long does Geodon withdrawal last?

Acute symptoms typically peak in the first week and resolve over 2-3 weeks. Relapse risk extends longer.

Important: This page is informational and does not constitute medical advice or a recommendation to start, stop, or change any medication. Tapering psychiatric medications should always be coordinated with the prescribing physician. Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.

Browse all medication withdrawal guides.